136 studies found for:    "branchio-oculo-facial syndrome" OR "Craniofacial Abnormalities"
Show Display Options
Rank Status Study
21 Terminated Infection in DiGeorge Following CHD Surgery
Conditions: DiGeorge Syndrome;   Congenital Heart Defects
Intervention:
22 Unknown  Genetic Modifiers for 22q11.2 Syndrome
Condition: 22q11.2 Deletion Syndrome
Intervention: Other: Observation
23 Active, not recruiting Thymus Transplantation in DiGeorge Syndrome #668
Conditions: DiGeorge Syndrome;   Complete Typical DiGeorge Anomaly
Intervention: Biological: Thymus Tissue for Transplantation
24 Recruiting Immune Disorder HSCT Protocol
Conditions: Immune Deficiency Disorders:;   Severe Combined Immunodeficiency;   Chronic Granulomatous Disease;   X-linked Agammaglobulinemia;   Wiskott-Aldrich Syndrome;   Hyper-IgM;   DiGeorge Syndrome;   Chediak-Higashi Syndrome;   Common Variable Immune Deficiency;   Immune Dysregulatory Disorder:;   Hemophagocytic Lymphohistiocytosis;   IPEX;   Autoimmune Lymphoproliferative Syndrome;   X-linked Lymphoproliferative Syndrome
Intervention: Drug: Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan
25 Completed
Has Results
Short-term Behavioral Effects of Cholesterol Therapy in Smith-Lemli-Opitz Syndrome
Condition: Smith-Lemli-Opitz Syndrome
Intervention: Drug: Dietary cholesterol supplementation
26 Completed Middle and Inner Ear Malformation in Children With Velocardiofacial Syndrome
Condition: Ear Malformations in the Velocardiofacial Syndrome
Intervention:
27 Recruiting Brain Characteristics Noted Prior to and Following Treatment
Condition: Nonsynostotic Plagiocephaly
Intervention: Other: Non-interventional
28 Active, not recruiting Pilot Study Evaluating Characteristic Closure Patterns of the Normal Velopharyngeal Portal
Condition: Cleft Palate
Intervention: Other: Normal Velopharyngeal Mechansim
29 Completed The Effect of Deliberate Hypotension on QTc, Tp-e Intervals and Heart Rate Variability
Conditions: Mandibular Prognathism,;   Mandibular Retrognathism
Interventions: Drug: Group R;   Drug: Group N;   Drug: Group D
30 Recruiting Evaluation and Intervention for the Effects of Osteogenesis Imperfecta
Conditions: Dwarfism;   Osteogenesis Imperfecta
Intervention:
31 Completed Study of Phenotype and Genotype Correlations in Patients With Contiguous Gene Deletion Syndromes
Conditions: Williams Syndrome;   Angelman Syndrome;   Prader-Willi Syndrome;   Shprintzen Syndrome;   Smith-Magenis Syndrome;   DiGeorge Syndrome;   Chromosome Abnormalities
Intervention:
32 Recruiting Timing of Primary Surgery for Cleft Palate
Condition: Cleft Palate
Intervention: Procedure: primary surgery for cleft palate
33 Completed Does Use of Rigid Fixation After Removing Distraction Osteogenesis Device Reduce the Relapse?
Conditions: Cleft Palate;   Maxillary Hypoplasia;   Maxillary Retrognathism
Intervention: Device: mini plate
34 Terminated Metyrosine (Demser®) for the Treatment of Psychotic Disorders in Patients With Velocardiofacial Syndrome
Conditions: Velo-cardio-facial Syndrome;   Psychosis
Interventions: Drug: Metyrosine;   Drug: Placebo
35 Recruiting The Efficacy and Population Pharmacokinetics of Tranexamic Acid for Craniosynostosis Surgery
Condition: Craniosynostosis
Interventions: Drug: high dose TXA;   Drug: Low dose TXA
36 Active, not recruiting Cell Therapy for Craniofacial Bone Defects
Conditions: Cleft Palate;   Trauma
Interventions: Biological: Ixmyelocel-T;   Procedure: Autogenous Bone Grafting
37 Completed Velocardiofacial (VCFS; 22q11.2; DiGeorge) Syndrome Study
Conditions: DiGeorge Syndrome;   Velocardiofacial Syndrome;   22q11.2 Syndrome
Intervention:
38 Recruiting Clinical and Genetic Studies on Holoprosencephaly
Condition: Holoprosencephaly
Intervention:
39 Recruiting Sterol and Isoprenoid Disease Research Consortium: Smith-Lemli-Opitz Syndrome
Condition: Smith-Lemli-Opitz Syndrome
Intervention: Dietary Supplement: Cholesterol supplementation
40 Unknown  The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome
Conditions: Velocardiofacial Syndrome;   Williams Syndrome;   Fragile X Syndrome
Intervention: Drug: methylphenidate, fluoxetin, risperidone

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years